Covered recipient · General Payments record
KYLE P ETZKORN
Allopathic & Osteopathic Physicians Internal Medicine Gastroenterology
General Payments · PY2018–2024
$12,869.59
- Reported across 131 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $439.37 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | $164.63 | 2 |
| ABBVIE INC. | $82.94 | 5 |
| Janssen Biotech, Inc. | $67.76 | 3 |
| GENZYME CORPORATION | $65.35 | 3 |
| PFIZER INC. | $15.71 | 1 |
| VIVUS LLC | $15.05 | 1 |
| Lilly USA, LLC | $14.63 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $13.30 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $28.21 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103701276 | CMS |
| ABBVIE INC. | $14.06 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103701278 | CMS |
| ABBVIE INC. | $13.38 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103701280 | CMS |
| ABBVIE INC. | $14.21 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103701282 | CMS |
| ABBVIE INC. | $13.08 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103701284 | CMS |
| GENZYME CORPORATION | $17.66 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139969991 | CMS |
| GENZYME CORPORATION | $26.80 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139969993 | CMS |
| GENZYME CORPORATION | $20.89 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139970003 | CMS |
| Janssen Biotech, Inc. | $25.81 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078428823 | CMS |
| Janssen Biotech, Inc. | $20.08 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078429865 | CMS |
| Janssen Biotech, Inc. | $21.87 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078428679 | CMS |
| Lilly USA, LLC | $14.63 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135142283 | CMS |
| PFIZER INC. | $15.71 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131257300 | CMS |
| Regeneron Healthcare Solutions, Inc. | $24.07 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114044605 | CMS |
| Regeneron Healthcare Solutions, Inc. | $140.56 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114044607 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $13.30 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137541917 | CMS |
| VIVUS LLC | $15.05 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1129415646 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.